Equities

TherapeuticsMD Inc

TherapeuticsMD Inc

Actions
  • Price (EUR)1.41
  • Today's Change0.000 / 0.00%
  • Shares traded16.00
  • 1 Year change-26.56%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 07:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4.333865
Total Receivables, Net3.09----
Total Inventory------
Prepaid expenses2.593.505.04
Other current assets, total1.791450
Total current assets1255119
Property, plant & equipment, net6.877.669.06
Goodwill, net------
Intangibles, net6.106.947.14
Long term investments------
Note receivable - long term18200
Other long term assets0.060.250.25
Total assets4390169
LIABILITIES
Accounts payable0.032.163.37
Accrued expenses2.721710
Notes payable/short-term debt000
Current portion long-term debt/capital leases--0188
Other current liabilities, total4.102751
Total current liabilities6.8547253
Total long term debt000
Total debt00188
Deferred income tax------
Minority interest------
Other liabilities, total7.178.4810
Total liabilities1455263
SHAREHOLDERS EQUITY
Common stock0.010.010.01
Additional paid-in capital979974958
Retained earnings (accumulated deficit)(950)(939)(1051)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity2935(94)
Total liabilities & shareholders' equity4390169
Total common shares outstanding129.508.60
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.